Deutivacaftor + Tezacaftor + Vanzacaftor
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Deutivacaftor
deutivacaftor - Tezacaftor
tezacaftor - Vanzacaftor
vanzacaftor
Brands with this exact combination
| Brand | Composition & strength | Manufacturer |
|---|---|---|
| vanzacaftor, tezacaftor, and deutivacaftorUS | 4 mg / 20 mg / 50 mg / 10 mg / 125 mg | Vertex Pharmaceuticals Incorporated |
| Generic Alyftrek 50mg/20mg/4mg tabletsGB | 50 mg / 20 mg / 4 mg / 125 mg / 10 mg | Vertex Pharmaceuticals (Europe) Ltd |
| Vanzacaftor + tezacaftor + deutivacaftorAU | 10 mg / 50 mg / 125 mg / 4 mg / 20 mg | Vertex Pharmaceuticals (Australia) Pty. Ltd. |
| deutivacaftor + vanzacaftor calcium + tezacaftorAU | — | — |
| ALYFTREK 10/50/125 vanzacaftor (as calcium) 10 mg / tezacaftor 50 mg / deutivacaftor 125 mg film-coated tablet blister packAU |
| Vertex Pharmaceuticals Australia Pty Ltd |
| ALYFTREK 4/20/50 vanzacaftor (as calcium) 4 mg / tezacaftor 20 mg / deutivacaftor 50 mg film-coated tablet blister packAU |
| Vertex Pharmaceuticals Australia Pty Ltd |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.